- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00195182
Psychosocial Determinants of Medication Adherence in Hypertensive African Americans
The specific aims for this study are:
- To examine the relationship between perceived racism and medication adherence among hypertensive African-American patients.
- To determine if psychological stress and depression mediate the relationship between perceived racism and medication adherence.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Achieving and maintaining recommended blood pressure goals in hypertensive African Americans is paramount to addressing racial disparities in hypertension-related morbidity and mortality. Because antihypertensive therapy is the cornerstone of hypertension management, good medication adherence is the key to adequate blood pressure control. Successful approaches to racial disparities must address how to increase adherence to anti-hypertensive medications.
Adherence to anti-hypertensive medications is likely multifactorial, and not solely related to SES or access to medical care. Psychosocial factors such as stress and depression have been implicated as important determinants of medication adherence. However, little is known about how other psychosocial factors such as perceived racism impact anti-hypertensive medication adherence. Understanding these relationships may assist in the development of targeted strategies to achieve good medication adherence in hypertensive patients.
The objective is to understand the relationships between perceived racism and medication adherence, while examining the role of depression, psychological stress, and self-efficacy in a population of hypertensive African-American patients. 262 African American adult hypertensive patients will be recruited from an urban academic general medicine practice. Baseline data collection will include assessments of demographics and socioeconomic status, clinical history and hypertension characteristics, depressive symptoms, perceived stress, and medication adherence. Patients will be followed for 1 year, when final evaluations will take place, including assessment of hypertension, stress, depression, medication adherence and level of perceived racism (measured by a validated instrument). The primary outcome is the change in medication adherence scores from baseline to 12 months. Statistical models will be developed to determine if level of perceived racism is associated with medication adherence, and whether stress and depression play a role in this relationship.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10021
- New York Presbyterian Hospital-Weill Medical College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients must be self-identified as African American.
- All patients must be aged 18 years or older.
- All patients must be diagnosed as having hypertension (for this project, hypertension will be defined according to the widely accepted criteria of the 6th Joint National Committee Guidelines on Prevention, Detection, Evaluation and Treatment of Hypertension, specifically a systolic blood pressure >140 mm hg or a diastolic blood pressure >90 mm hg) or if patients are taking any prescribed anti-hypertensive medication.
- Patients must be able to provide informed consent in English.
Exclusion Criteria:
- Patients who are unable to walk several blocks for any reason.
- Patients who refused to participate.
- Patients who are unable to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1. No intervention
This group received follow-up every 2-months for one year.
Follow-up included questions about their blood pressure and how well they had been able to adhere to their medication goal.
|
During the physical activity goal setting process, subjects were randomly assigned to either the control or the intervention group.
The intervention included receiving an additional educational workbook about using positive affect and self affirmation, as well as participating in using positive affect and self-affirmation to motivate behavior change, which in this case was to increase their medication adherence.
Patient also received small token gifts to remind them of their participation in the study and to induce positive affect.
The control group also set a physical activity goal and received the same follow-up, but did not participate in the positive affect and self-affirmation portion.
|
2. Experimental
This group received follow-up every 2-months for one year.
Follow-up included questions about their blood pressure and how well they had been able to engage adhere to their medication goal.
The intervention included receiving an additional educational workbook about using positive affect and self affirmation, as well as participating in using positive affect and self-affirmation to motivate behavior change, which in this case was to increase their physical activity level.
|
During the physical activity goal setting process, subjects were randomly assigned to either the control or the intervention group.
The intervention included receiving an additional educational workbook about using positive affect and self affirmation, as well as participating in using positive affect and self-affirmation to motivate behavior change, which in this case was to increase their medication adherence.
Patient also received small token gifts to remind them of their participation in the study and to induce positive affect.
The control group also set a physical activity goal and received the same follow-up, but did not participate in the positive affect and self-affirmation portion.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
To evaluate intervention of induced positive affect and induced self-affirmation will increase medication adherence among African-American hypertensive patients.
Time Frame: every two months for one year
|
every two months for one year
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Joseph E Ravenell, MD, MS, University of Texas Southwestern Medical Center
Publications and helpful links
General Publications
- Ravenell JE, Charlson ME. Stressed out: Definitions of stress among hypertensive African American men. Journal of General Internal Medicine 20(S1):128, 2005.
Study record dates
Study Major Dates
Study Start
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0302006001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Addpharma Inc.Completed
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sulaiman AlRajhi CollegesUnknownHypertension, Essential | β-hydroxybutyrate
-
Centre Chirurgical Marie LannelongueUnknownChronic Thrombo-embolic Pulmonary Hypertension and Pulmonary Arterial HypertensionFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
Clinical Trials on Self affirmation and positive affect induction vs. control
-
Weill Medical College of Cornell UniversityCompletedAngioplasty PatientsUnited States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedAngioplasty PatientsUnited States
-
Weill Medical College of Cornell UniversityCompletedHypertensionUnited States
-
Weill Medical College of Cornell UniversityCompleted
-
Weill Medical College of Cornell UniversityCompletedAsthmaUnited States
-
Weill Medical College of Cornell UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHypertensionUnited States
-
Weill Medical College of Cornell UniversityNational Institute on Minority Health and Health Disparities (NIMHD)Completed
-
Weill Medical College of Cornell UniversityCompleted
-
University of SussexEconomic and Social Research Council, United KingdomCompletedAlcohol DrinkingUnited Kingdom
-
University of NottinghamNorthumbria UniversityCompleted